[13 May 2013]
Products Affected - Description
Demerol hydrochloride injection, Hospira
50 mg/mL, 30 mL multi-dose vial (NDC 00409-1181-30)
Reason for the Shortage
Hospira has Demerol injection on shortage due to increased demand and manufacturing delays.
Available Products
Meperidine hydrochloride injection, West-Ward
25 mg/mL, 1 mL vials (NDC 00641-6052-25)
50 mg/mL, 1 mL vials (NDC 00641-6053-25)
100 mg/mL, 1 mL vials (NDC 00641-6054-25)
Demerol hydrochloride injection, Hospira
10 mg/mL, 30 mL vials for PCA (NDC 00409-6030-04)
25 mg/mL, 1 mL Carpuject syringe (NDC 00409-1176-30)
50 mg/mL, 0.5 mL ampules (NDC 00409-1203-01)
50 mg/mL, 1 mL ampules (NDC 00409-1253-01)
50 mg/mL, 1.5 mL ampules (NDC 00409-1254-01)
50 mg/mL, 1 mL Carpuject syringe (NDC 00409-1178-30)
50 mg/mL, 2 mL ampules (NDC 00409-1255-02)
75 mg/mL, 1 mL Carpuject syringe (NDC 00409-1179-30)
100 mg/mL, 1 mL ampules (NDC 00409-1256-01)
100 mg/mL, 1 mL Carpuject syringe (NDC 00409-1180-69)
100 mg/mL, 20 mL multi-dose vial (NDC 00409-1201-20)
Estimated Resupply Dates
- Hospira has Demerol 50 mg/mL 30 mL multi-dose vials on back order with an estimated release date of late-May 2013.
Related Shortages
Updated
May 13, 2013; April 3, 2013; March 28, 2013; March 4, 2013; February 20, 2013; January 28, 2013; January 14, 2013; December 21, 2012; December 12, 2012; October 30, 2012; October 15, 2012; September 19, 2012; August 13, 2012; July 31, 2012; June 21, 2012; May 11, 2012; April 20, 2012; April 4, 2012; March 20, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins